Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-24 @ 3:48 PM
NCT ID:
NCT00498992
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of cancer
* Starting treatment with cetuximab or other EGFR inhibitor (e.g., erlotinib hydrochloride) on another clinical trial
PATIENT CHARACTERISTICS:
* Not pregnant or nursing
* No known history of hypersensitivity to amine-type local anesthetics or to other components of MPM Regenecare® wound gel
* No other concurrent, serious skin disorders (i.e., scleroderma or psoriasis) that would interfere with assessment of EGFR inhibitor-induced rash
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No other concurrent topical facial creams or lotions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00498992
Study Brief:
Protocol Section:
NCT00498992